Manhattan Associates (MANH) – Research Analysts’ Weekly Ratings Changes

by · The Markets Daily

Manhattan Associates (NASDAQ: MANH) recently received a number of ratings updates from brokerages and research firms:

  • 11/2/2026 – Manhattan Associates had its price target raised by Barclays from $239.00 to $275.00. They now have an “overweight” rating on the stock.
  • 11/1/2026 – Manhattan Associates was downgraded by Wall Street Zen from “buy” to “hold”.
  • 10/28/2026 – Manhattan Associates was given a new $305.00 price target by UBS Group.
  • 10/28/2026 – Manhattan Associates had its price target raised by Stifel Nicolaus from $250.00 to $300.00. They now have a “buy” rating on the stock.
  • 10/28/2026 – Manhattan Associates had its price target raised by Citigroup from $260.00 to $280.00. They now have a “buy” rating on the stock.
  • 10/28/2026 – Manhattan Associates had its price target raised by DA Davidson from $210.00 to $230.00. They now have a “neutral” rating on the stock.
  • 10/28/2026 – Manhattan Associates had its “buy” rating reaffirmed by Truist Financial. They now have a $305.00 price target on the stock, up from $240.00.
  • 10/24/2026 – Manhattan Associates was upgraded by Wall Street Zen from “hold” to “buy”.
  • 10/20/2026 – Manhattan Associates had its price target raised by Citigroup from $203.00 to $260.00. They now have a “buy” rating on the stock.
  • 10/14/2026 – Manhattan Associates had its “buy” rating reaffirmed by UBS Group.
  • 10/14/2026 – Manhattan Associates had its price target raised by Stifel Nicolaus from $225.00 to $250.00. They now have a “buy” rating on the stock.
  • 10/12/2026 – Manhattan Associates was upgraded by Morgan Stanley from “equal weight” to “overweight”. They now have a $250.00 price target on the stock, up from $180.00.
  • 10/2/2026 – Manhattan Associates was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
  • 9/28/2026 – Manhattan Associates was given a new $210.00 price target by UBS Group.
  • 9/28/2026 – Manhattan Associates was downgraded by DA Davidson from “buy” to “neutral”. They now have a $210.00 price target on the stock.

Manhattan Associates Stock Down 0.4%

Shares of MANH traded down $1.06 during trading hours on Monday, reaching $251.72. 964,549 shares of the company traded hands, compared to its average volume of 768,541. The stock has a market capitalization of $14.62 billion, a PE ratio of 70.51 and a beta of 0.85. The stock has a fifty day simple moving average of $220.51 and a 200 day simple moving average of $168.75. Manhattan Associates, Inc. has a fifty-two week low of $119.06 and a fifty-two week high of $263.47.

Manhattan Associates (NASDAQ:MANH – Get Free Report) last announced its earnings results on Tuesday, October 27th. The software maker reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.09. The firm had revenue of $306.19 million during the quarter, compared to the consensus estimate of $297.01 million. Manhattan Associates had a net margin of 18.41% and a return on equity of 98.67%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.36 EPS. Research analysts predict that Manhattan Associates, Inc. will post 3.88 EPS for the current fiscal year.

Insider Transactions at Manhattan Associates

In other news, Director Linda Hollembaek sold 1,315 shares of the business’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $250.00, for a total value of $328,750.00. Following the completion of the transaction, the director owned 10,953 shares of the company’s stock, valued at $2,738,250. The trade was a 10.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Eric Clark sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $197.76, for a total transaction of $593,280.00. Following the completion of the transaction, the chief executive officer directly owned 89,638 shares of the company’s stock, valued at approximately $17,726,810.88. This represents a 3.24% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.84% of the company’s stock.

Read More